Open-Label, Single-Sequence, Two-Cohort Study to Evaluate the Effect of Darunavir/Cobicistat and Cobicistat on BMS-626529 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 01 Aug 2017
At a glance
- Drugs Fostemsavir (Primary) ; Cobicistat; Cobicistat/darunavir
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 21 Sep 2015 Results presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy
- 20 Jan 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov record.
- 09 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.